Skip to content
$
0.00
0
Cart
Search
(780) 448-0585
IOT.V 0.25 0.00 0.00%
Services
By Application
Anti-Adherence
Anti-Encrustation Testing
Antimicrobials
Environmental Bioburden Monitoring
Facility Water Testing
GMP Analytical Chemistry Testing Services
Medical Device Testing
MIC, MBC, MFC, Toxicology Testing
Microbiology Testing Services
Pharmaceutical & Drug Development
Stability Testing Services
Sterility Testing
By Method
Antimicrobial Effectiveness Testing USP <51>
BEST Assay™ Method
Environmental Bioburden Monitoring
GMP Analytical Chemistry Testing Services
MBEC Assay® Testing
Method Development and Validation Services
MIC, MBC, MFC, Toxicology Testing
By Industry
Compounding Pharmacies
Medical Device Testing
Pharmaceutical & Drug Development
Products
MBEC
InnovoSIL
Resources
Investor Relations
Company
Our Team / History
Careers
Quality
Contact
Contact Us
Annual and Interim Financial Statements
June 30, 2019
2019, Q2, 2019, for the three and six-month periods ended June 30, 2019 and 2018
March 31, 2019
2019, Q1, for the period ended March 31, 2019
December 31, 2018
Annual Financial Statements & MD&A For the 2018 year ended December 31
Page
1
Page
2
Page
3
